A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

Endostatin may predict mortality and kidney impairment in general populations as well as in critically ill patients. We decided to explore the possible role of endostatin as a predictor of 30-day mortality, acute kidney injury (AKI), and renal replacement therapy (RRT) in a cohort of unselected inte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Toralph Ruge, Anders Larsson, Miklós Lipcsey, Jonas Tydén, Joakim Johansson, Mats Eriksson
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
acute kidney injury
critical illness
endostatin
epidemiology
intensive care unit
mortality
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/d5522bcbbf0e4e03a6d8e2a7889f8211
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares